Leadership

The Harvard Stem Cell Institute is led by faculty directors Douglas Melton and David Scadden, and executive director Brock Reeve. Together with the Executive Committee, HSCI leadership brings together deep expertise in science and business from across Harvard and its teaching hospitals. Their combined intellectual venture capital guides HSCI’s strategy in harnessing the power of stem cell science to improve patients’ lives.

Faculty Directors

 
Douglas A. Melton, Ph.D.
Xander University Professor of Stem Cell and Regenerative Biology, Harvard University
Investigator, Howard Hughes Medical Institute
 
David T. Scadden, M.D.
Gerald and Darlene Jordan Professor of Medicine, Harvard University
Professor of Stem Cell and Regenerative Biology, Harvard University
Director, Center for Regenerative Medicine, Massachusetts General Hospital
 

Executive Director

 
Brock Reeve, M.Phil, M.B.A.
 

Executive Committee

 
Leonard Zon, M.D., Chair
Professor of Stem Cell and Regenerative Biology, Harvard University
Grousbeck Professor of Pediatrics, Harvard Medical School
Director, Stem Cell Program, Boston Children’s Hospital
Investigator, Howard Hughes Medical Institute
 
Joseph V. Bonventre, M.D., Ph.D.
Chief, Division of Renal Medicine, Brigham and Women’s Hospital
Chief, Division of Engineering in Medicine, Brigham and Women’s Hospital
Samuel A. Levine Professor, Harvard Medical School
 
Susan Dymecki, M.D., Ph.D.
Professor of Genetics, Harvard Medical School
 
Albert Edge, Ph.D.
Director, Tillotson Cell Biology Unit and Principal Investigator, Eaton-Peabody Laboratories, Massachusetts Eye and Ear
Professor of Otolaryngology —Head and Neck Surgery, Harvard Medical School
 
Jenna Galloway, Ph.D.
Assistant Professor, Center for Regenerative Medicine and Department of Orthopedic Surgery, Massachusetts General Hospital
HSCI Musculoskeletal Program Leader
 
Carla F. Kim, Ph.D.
Professor of Genetics and Professor of Pediatrics, Harvard Medical School
Principal Investigator, Stem Cell Program, Boston Children’s Hospital
 
Jeffrey Macklis, M.D., D.Sc.Tech.
Max and Anne Wien Professor of Life Sciences, Harvard University
Professor of Stem Cell and Regenerative Biology, Harvard University
Professor of Neurology, Harvard Medical School
Faculty Member, Harvard University Center for Brain Science
 
Jerome Ritz, M.D.
Executive Director, Connell and O’Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
 
Vicki Rosen, Ph.D.
Professor of Developmental Biology and Chair of the Department of Developmental Biology, Harvard School of Dental Medicine
HSCI Musculoskeletal Program Leader
 
Lee Rubin, Ph.D.
Professor of Stem Cell and Regenerative Biology, Harvard University
HSCI Nervous System Diseases Program Leader
 
Amy Wagers, Ph.D.
Forst Family Professor of Stem Cell and Regenerative Biology, Harvard University
Co-chair, Harvard Department of Stem Cell and Regenerative Biology
Senior Investigator, Joslin Diabetes Center
 

New faculty members 

 
In 2020, HSCI welcomed six new Principal Faculty members from schools and hospitals across our network.
 
Fei Chen, Ph.D.
Assistant Professor of Stem Cell and Regenerative Biology, Harvard University
Core Institute Member, Broad Institute of MIT and Harvard
 
Ryan Flynn, M.D., Ph.D.
Assistant Professor of Stem Cell and Regenerative Biology, Harvard University
Principal Investigator, Stem Cell Program, Boston Children’s Hospital
 
Ruth Franklin, Ph.D.
Assistant Professor of Stem Cell and Regenerative Biology, Harvard University
 
Leslie Kean, M.D., Ph.D.
Director, Stem Cell Transplant Center, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Robert A. Stranahan Professor of Pediatrics, Harvard Medical School
 
Kara McKinley, Ph.D.
Assistant Professor of Stem Cell and Regenerative Biology, Harvard University
 
Marc Wein, M.D., Ph.D.
Endocrine Unit, Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School